Shin-ichi Kohno

Intercellular trafficking and cytotoxicity of recombinant HSV-1 thymidine kinase fused with HSV-2 US11 RXP repeat peptide

F. Kikkawa, Y. Nishiyama, F. Goshima, 2007, Virus Genes.

Oncolytic virotherapy with an HSV amplicon vector expressing granulocyte–macrophage colony-stimulating factor using the replication-competent HSV type 1 mutant HF10 as a helper virus

T. Tsurumi, Y. Nishiyama, F. Goshima, 2007, Cancer Gene Therapy.

Herpes simplex virus type 1 mutant HF10 oncolytic viral therapy for bladder cancer.

Y. Nishiyama, T. Sata, F. Goshima, 2005, Urology.

Intratumoral injection of herpes simplex virus HF10 in recurrent head and neck squamous cell carcinoma

Y. Nishiyama, T. Nakashima, Y. Fujimoto, 2006, Acta oto-laryngologica.

Oncolytic viral therapy for breast cancer with herpes simplex virus type 1 mutant HF 10

Akimasa Nakao, A. Nakao, Y. Nishiyama, 2004, Journal of surgical oncology.